Kemocarb 150mg Injection 15 ml
About Kemocarb 150mg Injection 15 ml
Kemocarb 150mg Injection 15 ml belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
Kemocarb 150mg Injection 15 ml contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.
Kemocarb 150mg Injection 15 ml is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of Kemocarb 150mg Injection 15 ml do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
To treat your condition effectually, continue taking Kemocarb 150mg Injection 15 ml for as long as your doctor has prescribed. Do not stop the Kemocarb 150mg Injection 15 ml midway. Talk to your doctor before taking Kemocarb 150mg Injection 15 ml if you have severe allergic reactions to Kemocarb 150mg Injection 15 ml or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Kemocarb 150mg Injection 15 ml should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Kemocarb 150mg Injection 15 ml if you are pregnant or breastfeeding because this Kemocarb 150mg Injection 15 ml can cause harmful effects on the unborn baby. Both women and men using this Kemocarb 150mg Injection 15 ml should use birth control to avoid pregnancy.
Uses of Kemocarb 150mg Injection 15 ml
Medicinal Benefits
Kemocarb 150mg Injection 15 ml contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.
Directions for Use
Storage
Side Effects of Kemocarb 150mg Injection 15 ml
Drug Warnings
Kemocarb 150mg Injection 15 ml should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking Kemocarb 150mg Injection 15 ml. To treat your condition effectually, continue taking Kemocarb 150mg Injection 15 ml for as long as your doctor has prescribed. Do not stop the Kemocarb 150mg Injection 15 ml midway. Talk to your doctor before taking Kemocarb 150mg Injection 15 ml if you have severe allergic reactions to Kemocarb 150mg Injection 15 ml or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. Kemocarb 150mg Injection 15 ml should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking Kemocarb 150mg Injection 15 ml if you are pregnant or breastfeeding because this Kemocarb 150mg Injection 15 ml can cause harmful effects on the unborn baby. Both women and men using this Kemocarb 150mg Injection 15 ml should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during Kemocarb 150mg Injection 15 ml treatment and appropriate until recovery is achieved.
Drug Interactions
Drug-Drug Interactions: Kemocarb 150mg Injection 15 ml interacts with medicines used in the treatment of chemotherapy (e.g. pemetrexed, gemcitabine, pegfilgrastim, paclitaxel, docetaxel), antacid medications (e.g. pantoprazole) and antibiotic medications (e.g. amikacin, gentamicin, kanamycin, streptomycin, tobramycin).
Drug-Food Interactions: No food interaction was found.
Drug-Disease Interactions: Inform your doctor before taking Kemocarb 150mg Injection 15 ml it requires close monitoring if you are suffering from Infection (bacterial/fungal/protozoal/viral), bleeding disorders, bone marrow depression/low blood counts, fever, renal dysfunction or disorders, peripheral neuropathy (nerves malfunction).
Drug-Drug Interactions Checker List
Habit Forming
Diet & Lifestyle Advise
Special Advise
Disease/Condition Glossary
Ovarian cancer: Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed).
Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.